SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 6.21 billion. The enterprise value is 6.77 billion.

Market Cap	6.21B
Enterprise Value	6.77B

Important Dates

The next estimated earnings date is Wednesday, March 18, 2026.

Earnings Date	Mar 18, 2026
Ex-Dividend Date	Jul 1, 2025

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has decreased by -0.54% in one year.

Current Share Class	119.51M
Shares Outstanding	119.51M
Shares Change (YoY)	-0.54%
Shares Change (QoQ)	-0.77%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	0.60%
Float	69.80M

Valuation Ratios

The trailing PE ratio is 57.78.

PE Ratio	57.78
Forward PE	n/a
PS Ratio	4.62
PB Ratio	1.15
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	28.21
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.71, with an EV/FCF ratio of -17.36.

EV / Earnings	63.02
EV / Sales	5.04
EV / EBITDA	18.71
EV / EBIT	62.30
EV / FCF	-17.36

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.12.

Current Ratio	1.05
Quick Ratio	0.31
Debt / Equity	0.12
Debt / EBITDA	1.54
Debt / FCF	-1.61
Interest Coverage	31.45

Financial Efficiency

Return on equity (ROE) is 1.98% and return on invested capital (ROIC) is 2.55%.

Return on Equity (ROE)	1.98%
Return on Assets (ROA)	1.38%
Return on Invested Capital (ROIC)	2.55%
Return on Capital Employed (ROCE)	2.65%
Weighted Average Cost of Capital (WACC)	4.59%
Revenue Per Employee	5.62M
Profits Per Employee	449,264
Employee Count	239
Asset Turnover	0.19
Inventory Turnover	1.47

Taxes

Income Tax	-5.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.18% in the last 52 weeks. The beta is 0.13, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-39.18%
50-Day Moving Average	51.27
200-Day Moving Average	57.62
Relative Strength Index (RSI)	49.76
Average Volume (20 Days)	153,646

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.34 billion and earned 107.37 million in profits. Earnings per share was 0.90.

Revenue	1.34B
Gross Profit	351.03M
Operating Income	155.25M
Pretax Income	102.19M
Net Income	107.37M
EBITDA	408.21M
EBIT	155.25M
Earnings Per Share (EPS)	0.90

Full Income Statement

Balance Sheet

The company has 74.80 million in cash and 627.07 million in debt, giving a net cash position of -552.28 million or -4.62 per share.

Cash & Cash Equivalents	74.80M
Total Debt	627.07M
Net Cash	-552.28M
Net Cash Per Share	-4.62
Equity (Book Value)	5.39B
Book Value Per Share	45.45
Working Capital	54.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 220.32 million and capital expenditures -610.00 million, giving a free cash flow of -389.68 million.

Operating Cash Flow	220.32M
Capital Expenditures	-610.00M
Free Cash Flow	-389.68M
FCF Per Share	-3.26

Full Cash Flow Statement

Margins

Gross margin is 26.12%, with operating and profit margins of 11.55% and 7.99%.

Gross Margin	26.12%
Operating Margin	11.55%
Pretax Margin	7.61%
Profit Margin	7.99%
EBITDA Margin	30.38%
EBIT Margin	11.55%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 2.87%.

Dividend Per Share	1.50
Dividend Yield	2.87%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	2
Payout Ratio	166.67%
Buyback Yield	0.54%
Shareholder Yield	3.41%
Earnings Yield	1.73%
FCF Yield	-6.27%

Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.125

Scores

Altman Z-Score	n/a
Piotroski F-Score	5